<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Noncoding RNA Res</journal-id><journal-id journal-id-type="iso-abbrev">Noncoding RNA Res</journal-id><journal-title-group><journal-title>Non-coding RNA Research</journal-title></journal-title-group><issn pub-type="epub">2468-0540</issn><publisher><publisher-name>KeAi Publishing</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786793</article-id><article-id pub-id-type="pii">S2468-0540(25)00001-0</article-id><article-id pub-id-type="doi">10.1016/j.ncrna.2025.01.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Serum/glucose starvation enhances binding of miR-4745-5p and miR-6798-5p to <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR: A novel method to identify miRNAs binding to mRNA 3&#x002b9;UTR using &#x003bb;N peptide-boxB sequence</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Takahashi</surname><given-names>Tetsuyuki</given-names></name><email>te_taka@musashino-u.ac.jp</email><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Funamura</surname><given-names>Mai</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Wakai</surname><given-names>Shun</given-names></name></contrib><contrib contrib-type="author" id="au4"><name><surname>Hijikata</surname><given-names>Takao</given-names></name></contrib><aff id="aff1">Department of Anatomy and Cell Biology, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Nishi-Tokyo, Tokyo, 202-8585, Japan</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author. <email>te_taka@musashino-u.ac.jp</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>07</day><month>1</month><year>2025</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>07</day><month>1</month><year>2025</year></pub-date><volume>11</volume><fpage>188</fpage><lpage>199</lpage><history><date date-type="received"><day>21</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>4</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>6</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>Serum/glucose starvation causes complete loss of heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) without altering mRNA levels. However, the mechanisms driving hnRNP A1 downregulation during serum/glucose starvation are not yet well understood. Using the novel interaction between the &#x003bb;N peptide and boxB sequence (&#x003bb;N/boxB system) and miRNA microarray analysis, we aimed to identify specific-binding microRNAs (miRs or miRNAs) targeting <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR under serum/glucose-starved conditions. Four miRNAs were identified as serum/glucose starvation-driven miRNAs for <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. Reporter assays, anti-miRNA and mutated miRNA-based assays, photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation/reverse transcribed-quantitative polymerase chain reaction, and transient overexpression of miRNAs showed that miR-4745-5p and miR-6798-5p suppress hnRNP A1 protein levels via enhancement of binding to <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR under serum/glucose-starved condition. miR-4745-5p and miR-6798-5p overexpression significantly decreased growth rates, which was rescued by co-transfection with anti-miRNA for miR-4745-5p and miR-6798-5p. Anti-miRNA transfection for miR-4745-5p and miR-6798-5p significantly increased growth rates under serum/glucose-starved conditions. Furthermore, hnRNP A1 overexpression recovered miR-4745-5p- and miR-6798-5p-induced growth suppression. These findings indicated that miR-4745-5p and miR-6798-5p are serum/glucose starvation-driven miRNAs for hnRNP A1 and validated the &#x003bb;N/boxB system as a simple and useful method for detecting mRNA 3&#x002b9;UTR-bound miRNA.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>microRNA</kwd><kwd>hnRNP A1</kwd><kwd>&#x003bb;N/boxB system</kwd><kwd>Serum/glucose starvation</kwd><kwd>Microarray</kwd><kwd>miR-4745-5p</kwd><kwd>miR-6798-5p</kwd></kwd-group></article-meta><def-list><title>Abbreviations</title><def-item><term id="kwrd0050">hnRNP A1</term><def><p>heterogeneous nuclear ribonucleoprotein A1</p></def></def-item><def-item><term id="kwrd0060">PAR-CLIP</term><def><p>photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation</p></def></def-item><def-item><term id="kwrd0070">RISC</term><def><p>RNA-induced silencing complex</p></def></def-item></def-list></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) is an RNA-binding protein involved in mRNA splicing, transport, stability, transcriptional and translational regulation, and telomere maintenance via specific binding to the target sequence [<xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>]. These functions of hnRNP A1 contribute to cellular homeostasis and protect normal movements of RNA in cells. Overexpression or dysfunction of hnRNP A1 is found in lesions of diseases, including neurodegenerative disorders and cancers [<xref rid="bib3" ref-type="bibr">3</xref>,<xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>]. We previously reported that serum/glucose-starved conditions, which mimics undernutrition in lesions of incomplete blood supply (e.g., within the core of tumors or lesions of cerebral and myocardial infarction), leads to a complete loss of hnRNP A1 without any corresponding changes in mRNA levels in HeLa cervical cancer cells [<xref rid="bib18" ref-type="bibr">18</xref>]; however, the definitive molecular mechanism of this downregulation in serum/glucose-starved conditions remains unknown.</p><p id="p0015">We hypothesized that translational suppression participates in this process. miRNA, recognized as a key translational regulator [<xref rid="bib19" ref-type="bibr">19</xref>], binds to the 3&#x002b9;UTR of target mRNA via specific nucleotide sequences (seed sequences), and cellular stresses, including serum starvation, can alter of particular miRNA levels, reducing specific protein levels [<xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>].</p><p id="p0020">To detect miRNAs involved in hnRNP A1 loss under serum/glucose-starved conditions, we established a novel miRNA detection system, &#x003bb;N/boxB. This &#x003bb;N/boxB system uses a pulldown method with cell lysates that co-expresses a tag protein-fused &#x003bb;N peptide and boxB sequence-fused RNA (This system is customizable, allowing design of specific tag proteins and RNA sequences as needed). This study aimed to identify miRNAs that contribute to the loss of hnRNP A1 protein under serum/glucose-starved conditions and investigate their effects on cellular growth.</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Cells</title><p id="p0025">Human cervical cancer HeLa cells were maintained in DMEM (Wako, Osaka, Japan) supplemented with 10&#x000a0;% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, USA), 100 units/mL of penicillin G (Wako), and 0.1&#x000a0;mg/mL of streptomycin sulfate (Wako).</p></sec><sec id="sec2.2"><label>2.2</label><title>Plasmids</title><p id="p0030">This study used various mammalian expression plasmids including pZac, pZac-5&#x000a0;&#x000d7;&#x000a0;boxB, pZac-RNP3&#x002b9;UTR-5&#x000a0;&#x000d7;&#x000a0;boxB, pZac-RNP3&#x002b9;UTR/miR-4734mt-5&#x000a0;&#x000d7;&#x000a0;boxB, pZac-RNP3&#x002b9;UTR/miR-4745mt-5&#x000a0;&#x000d7;&#x000a0;boxB, pZac-RNP3&#x002b9;UTR/miR-6126mt-5&#x000a0;&#x000d7;&#x000a0;boxB, pZac-RNP3&#x002b9;UTR/miR-6798mt-5&#x000a0;&#x000d7;&#x000a0;boxB, pQCXIP, pQCXIP-RNPA1-HA, which is not inserted the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR, and the &#x003bb;N peptide-fused Halo-Tag expression plasmid pFC-&#x003bb;N-HA-Halo. Additionally, then luciferase reporter plasmids included pGL, pRL-CMV, pRL-Luc-RNP3&#x002b9;UTR, pRL-Luc-RNP3&#x002b9;UTR/miR-4734mt, pRL-Luc-RNP3&#x002b9;UTR/miR-4745mt, pRL-Luc-RNP3&#x002b9;UTR/miR-6126mt, and pRL-Luc-RNP3&#x002b9;UTR/miR-6798mt. Retroviral miRNA expression plasmids included pSIREN-RetroQ (pSRQ), pSRQ-miR4734, pSRQ-miR4745, pSRQ-miR6126, and pSRQ-miR6798. The procedure of plasmid construction and primer sequences are provided in the supporting information and <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>, respectively.</p></sec><sec id="sec2.3"><label>2.3</label><title>Serum/glucose starvation</title><p id="p0035">Serum/glucose starvation was performed by replacing the medium with to serum-free glucose-deprived DMEM (Wako) after washing the cells twice with phosphate-buffered saline. The glucose-deprived DMEM was changed every 3 weeks to maintain the condition as fresh condition.</p></sec><sec id="sec2.4"><label>2.4</label><title>Reverse transcription-polymerase chain reaction (RT-PCR)</title><p id="p0040">Total RNA (500 ng/reaction) from transfected cells was reverse transcribed using a random hexamer and ReverTra Ace (TOYOBO, Osaka, Japan) following the manufacturer's protocol. Semiquantitative RT-PCR was conducted with cDNAs obtained from reverse transcription using PrimeStar GXL (Takara Bio Japan, Shiga, Japan) for pZac-based vector-derived RNAs and actin mRNA (an internal control). The thermocycling program included initial denaturation at 94&#x000a0;&#x000b0;C for 2&#x000a0;min; 30 cycles of amplification at 98&#x000a0;&#x000b0;C for 10&#x000a0;s, 60&#x000a0;&#x000b0;C for 15&#x000a0;s, and 68&#x000a0;&#x000b0;C for 3&#x000a0;min; and a final extension at 68&#x000a0;&#x000b0;C for 10&#x000a0;min. RT-PCR products were separated using 1.5&#x000a0;% agarose gel electrophoresis and were subsequently visualized using a UV transilluminator. The primer sequences used in this experiment are listed in <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>.</p></sec><sec id="sec2.5"><label>2.5</label><title>Immunoblotting</title><p id="p0045">Cells were lysed with 2&#x000a0;&#x000d7;&#x000a0;SDS sample buffer (50&#x000a0;mM Tris-HCl at pH 6.8, 10&#x000a0;% glycerol, 2&#x000a0;% SDS, 0.1&#x000a0;% bromophenol blue, and 0.2&#x000a0;M dithiothreitol [DTT]) and a Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA, USA) was used to quantify sample protein concentrations. Subsequently, cell lysates (12&#x000a0;&#x003bc;g of protein) were subjected to SDS-PAGE (10&#x000a0;% gel) and transferred to polyvinylidene fluoride membranes. The ECL-Prime Western Blotting Detection Reagent (GE Healthcare UK, Buckinghamshire, UK) was used to detect immunoreactive signals. Antibodies used in this study are listed in the supporting information. A mouse antibody against HaloTag (1:1000; G9211, Promega, Madison, WI, USA), rabbit antibody against hnRNP A1 (1:2000; GTX106208, GeneTex, Alton Parkway Irvine, CA, USA), and mouse antibody against &#x003b2;-actin (1:5000; clone AC-15, Sigma-Aldrich) were used as primary antibodies. Goat anti-rabbit IgG-HRP and goat anti-mouse IgG-HRP (both at 1:5000; Sigma-Aldrich) were used as secondary antibodies.</p></sec><sec id="sec2.6"><label>2.6</label><title>Isolation of HNRNPA1 mRNA 3&#x002b9;UTR-bound RNAs via the &#x003bb;N/boxB system</title><p id="p0050">Cells (2&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup>) were seeded into 100-mm dishes and preincubated for 16&#x000a0;h at 37&#x000a0;&#x000b0;C. Thereafter, cells were co-transfected with 5&#x000a0;&#x000d7;&#x000a0;boxB-fused RNA- and Halo tag-fused &#x003bb;N-expression vectors using polyethyleneimine MAX (Polysciences, Warrington, PA, USA). Cells were subsequently lysed with avidin-pulldown lysis buffer (20&#x000a0;mM Tris-HCl pH 7.4, 100&#x000a0;mM KCl, 5&#x000a0;mM MgCl<sub>2</sub>, 0.5&#x000a0;% NP-40, and 0.5&#x000a0;mM DTT) supplemented with RNaseOUT (Invitrogen, Carlsbad, CA, USA) and pulled down with HaloLink&#x02122; Resin (Promega) for 1&#x000a0;h at 25&#x000a0;&#x000b0;C. RNAs from the resultant precipitate were isolated using ISOGEN (Nippon Gene, Osaka, Japan) and dissolved with 15&#x000a0;&#x003bc;L of RNase-free H<sub>2</sub>O.</p></sec><sec id="sec2.7"><label>2.7</label><title>miRNA microarray</title><p id="p0055">Pulled-down RNAs from the &#x003bb;N/boxB system were analyzed with a miRNA microarray analysis contract service using Affymetrix GeneChip&#x02122; miRNA 4.0 Array (Filgen, Nagoya, Japan). Fold-change values were calculated by dividing the normalized expression value in starved cells by that in normal cells.</p></sec><sec id="sec2.8"><label>2.8</label><title>Reverse transcription-quantitative polymerase chain reaction (qPCR)</title><p id="p0060">Using total, pulled-down, and isolated RNAs following photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP), miR-197-5p, miR-4530, miR-4734, miR-4745-5p, miR-6126, miR-6791-5p, miR-6798-5p, miR-6831-5p, <italic>U6</italic>, <italic>HNRNPA1</italic> mRNA, <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR, and <italic>ACTB</italic> mRNA levels were determined using qPCR. <italic>U6</italic> and <italic>ACTB</italic> served as internal standards. Detailed procedures have been described in our previous reports [<xref rid="bib18" ref-type="bibr">18</xref>,<xref rid="bib25" ref-type="bibr">25</xref>]. Primer sequences used in this experiment are listed in <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>.</p></sec><sec id="sec2.9"><label>2.9</label><title>miRNA and anti-miRNA transfection</title><p id="p0065">Using the Dharmafect 1 reagent (Dharmacon, Lafayette, CO, USA), cells were transfected with biotinylated mature miR-4734, miR-4745-5p, miR-6126, miR-6798-5p (Fasmac, Kanagawa, Japan), biotinylated mature miR-4734 mutant (mt), miR-4745-5p mt, miR-6126 mt, miR-6798-5p mt (Fasmac), miRDIAN&#x02122; microRNA inhibitor of miR-4734, miR-4745-5p, miR-6126, miR-6798-5p (Dharmacon), unbiotinylated miR-4734 mt, miR-4745-5p mt, miR-6126 mt, miR-6798-5p mt (Fasmac), and universal negative control (Dharmacon) according to the manufacturer's protocol. Cells were used for downstream experiments 24&#x000a0;h after transfection.</p></sec><sec id="sec2.10"><label>2.10</label><title>Biotinylated miRNA pulldown and qPCR</title><p id="p0070">Biotinylated miRNA-transfected cells were lysed with avidin-pulldown lysis buffer supplemented with RNaseOUT (Invitrogen) and pulled down with streptavidin-conjugated Dynabeads&#x02122; magnetic beads (Invitrogen) for 1&#x000a0;h at 25&#x000a0;&#x000b0;C. Thereafter, pulled-down RNAs were isolated and subjected to qPCR for <italic>HNRNPA1</italic> RNA mRNA 3&#x002b9;UTR, as described above (2.6. and 2.8.).</p></sec><sec id="sec2.11"><label>2.11</label><title>Luciferase assay using the HNRNPA1 mRNA 3&#x002b9;UTR</title><p id="p0075">Cells were co-transfected with the internal pGL control vector and pRL-based reporter vectors at a molar ratio of 1:10 (total 550&#x000a0;ng vectors) using polyethylenimine MAX (Polysciences). After 48&#x000a0;h, relative luciferase activities were determined using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol. Relative activities were calculated by dividing the pRL value by the pGL value.</p></sec><sec id="sec2.12"><label>2.12</label><title>PAR-CLIP/qPCR</title><p id="p0080">Cells incubated under normal or serum/glucose-starved conditions were subjected to PAR-CLIP using mouse anti-Ago2 or mouse IgG (1:100 each; Wako). The detailed procedure is described in our previous report (18). RNAs in the Ago2-associated immunocomplex were isolated with ISOGEN (Nippon Gene) and dissolved with 15&#x000a0;&#x003bc;L of RNase-free H<sub>2</sub>O. miR-4734, miR-4745-5p, miR-6126, miR-6798-5p, and <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR levels were determined using qPCR.</p></sec><sec id="sec2.13"><label>2.13</label><title>Growth assays</title><p id="p0085">Control and transfected cells were plated on 96-well plates (1&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup>&#x000a0;cells/well or 2&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup>&#x000a0;cells/well), preincubated for 16&#x000a0;h and then subsequently incubated in complete or serum/glucose-starved culture media for 24, 48, and 72&#x000a0;h. Viable cells were counted using the WST-8 assay (Dojindo, Kumamoto, Japan) following incubation.</p></sec><sec id="sec2.14"><label>2.14</label><title>Statistical analyses</title><p id="p0090">All comparisons were performed using the two-tailed Student's <italic>t</italic>-test, and differences were considered statistically significant at <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Identification of HNRNPA1 mRNA 3&#x002b9;UTR-bound miRNAs using the &#x003bb;N/boxB system</title><p id="p0095">miRNAs bound to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR were isolated using the &#x003bb;N/boxB system (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A). HeLa cells were co-transfected with a 5&#x000a0;&#x000d7;&#x000a0;tandem boxB-fused RNA-expression vector and Halo tag-fused &#x003bb;N-expression vector. The 5&#x000a0;&#x000d7;&#x000a0;boxB-fused RNA and Halo tag-fused &#x003bb;N interacted, forming a complex that can be isolated via pulldown using HaloLink resin. miRNAs bound to the 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR were isolated and identified via miRNA microarray analysis. Prior to identification, we performed a preliminary experiment to determine whether 5&#x000a0;&#x000d7;&#x000a0;boxB-fused RNA and Halo Tag-fused &#x003bb;N peptides are expressed under serum/glucose-starved conditions. RT-PCR using vector-specific primers (between F1, F2, and R1; <xref rid="fig1" ref-type="fig">Fig. 1</xref>B) and immunoblotting confirmed the expression of 5&#x000a0;&#x000d7;&#x000a0;boxB-fused RNA and Halo Tag-fused &#x003bb;N peptide under both normal and serum/glucose-starved conditions. Furthermore, immunoblotting revealed that serum/glucose starvation caused loss of hnRNP A1, except in 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-expressing cells (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C). This suggested that the 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR likely acted as a decoy for miRNAs targeting endogenous <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. As in our previous report [<xref rid="bib18" ref-type="bibr">18</xref>], serum/glucose-starvation did not induce cell death in HeLa cells. Additionally, no cytotoxicity induced by co-transfection was observed microscopically at least 48&#x000a0;h post-transfection (data not shown). An miRNA microarray was used to identify miRNAs preferentially binding to <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR under serum/glucose starvation. Microarray analysis revealed increased binding of 56 miRNAs to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (52 miRNAs were &#x0003e;2.0-fold, and 4 were &#x0003e;4.0-fold; <xref rid="fig1" ref-type="fig">Fig. 1</xref>D). Conversely, decreased binding to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR was observed in 27 miRNAs (25 miRNAs were &#x0003c;0.5-fold and 2 were &#x0003e;0.25-fold; <xref rid="fig1" ref-type="fig">Fig. 1</xref>D and <xref rid="appsec1" ref-type="sec">Supplementary Table 2</xref>). miRNAs with altered binding were subsequently filtered through public databases TargetScanHuman 7.1 (<ext-link ext-link-type="uri" xlink:href="https://www.targetscan.org/vert_71/" id="intref0010">https://www.targetscan.org/vert_71/</ext-link>) and miRDB (<ext-link ext-link-type="uri" xlink:href="https://mirdb.org/" id="intref0015">https://mirdb.org/</ext-link>) to determine their potential binding to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. Seventeen miRNAs were further identified as likely to bind to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR via their seed sequence (<xref rid="tbl1" ref-type="table">Table 1</xref>).<fig id="fig1"><label>Fig. 1</label><caption><p><bold>Identification of serum/glucose starvation-driven miRNA targeting <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR.</bold> A. Schematic flowchart of identification for <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-binding miRNA identification the &#x003bb;N/boxB system combined with miRNA microarray. B. Construction chart for the 5&#x000a0;&#x000d7;&#x000a0;boxB-fused RNA-expression vector. <italic>Red</italic>, multiple cloning site; <italic>F1</italic>, <italic>F2</italic>, and <italic>R1</italic>, positions of detection primers for RT-PCR. Estimated PCR product sizes are listed in bottom table. C. Representative pictures of RT-PCR and immunoblotting in HeLa cells co-transfected with the indicated vectors. Each combination of cotransfection was performed under normal and serum/glucose-starved conditions. D. Summary of miRNA microarray results and subsequent flowchart for candidate miRNA determination.</p></caption><alt-text id="alttext0025">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Up- and downregulated miRNAs bound to <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR by serum/glucose starvation.</p></caption><alt-text id="alttext0050">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>miRNA</th><th>fold change(stavation/10&#x000a0;% FBS)</th><th>predicted binding position at <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (nt1-nt2543)</th><th>guide strand sequence (5&#x02032; to 3&#x02032;)</th></tr></thead><tbody><tr><td align="left">hsa-miR-6126</td><td align="char">4.064617404</td><td align="left">982&#x02013;988</td><td align="left">GUGAAGGCCCGGCGGAGA</td></tr><tr><td align="left">hsa-miR-1231</td><td align="char">3.952873399</td><td align="left">1664&#x02013;1670</td><td align="left">GUGUCUGGGCGGACAGCUGC</td></tr><tr><td align="left">hsa-miR-6831-5p</td><td align="char">3.128196597</td><td align="left">1114&#x02013;1120</td><td align="left">UAGGUAGAGUGUGAGGAGGAGGUC</td></tr><tr><td align="left">hsa-miR-197-5p</td><td align="char">2.49929397</td><td align="left">752&#x02013;758</td><td align="left">CGGGUAGAGAGGGCAGUGGGAGG</td></tr><tr><td align="left">hsa-miR-4530</td><td align="char">2.302630659</td><td align="left">832&#x02013;838</td><td align="left">CCCAGCAGGACGGGAGCG</td></tr><tr><td align="left">hsa-miR-4734</td><td align="char">2.255311085</td><td align="left">858&#x02013;864</td><td align="left">GCUGCGGGCUGCGGUCAGGGCG</td></tr><tr><td align="left">hsa-miR-4745-5p</td><td align="char">2.18571267</td><td align="left">755&#x02013;761</td><td align="left">UGAGUGGGGCUCCCGGGACGGCG</td></tr><tr><td align="left">hsa-miR-16-5p</td><td align="char">2.231314498</td><td align="left">107&#x02013;113</td><td align="left">UAGCAGCACGUAAAUAUUGGCG</td></tr><tr><td align="left">hsa-miR-6791-5p</td><td align="char">2.122347564</td><td align="left">814&#x02013;820</td><td align="left">CCCCUGGGGCUGGGCAGGCGGA</td></tr><tr><td align="left">hsa-miR-6798-5p</td><td align="char">2.026211607</td><td align="left">761&#x02013;768</td><td align="left">CCAGGGGGAUGGGCGAGCUUGGG</td></tr><tr><td align="left">hsa-miR-3613-5p</td><td align="char">0.114919173</td><td align="left">60&#x02013;66</td><td align="left">UGUUGUACUUUUUUUUUUGUUC</td></tr><tr><td align="left">hsa-miR-6750-5p</td><td align="char">0.277104621</td><td align="left">748&#x02013;754</td><td align="left">CAGGGAACAGCUGGGUGAGCUGCU</td></tr><tr><td align="left">hsa-miR-1298-3p</td><td align="char">0.281283325</td><td align="left">624&#x02013;630</td><td align="left">CAUCUGGGCAACUGACUGAAC</td></tr><tr><td align="left">hsa-miR-378h</td><td align="char">0.31354268</td><td align="left">1782-1788, 1830&#x02013;1836</td><td align="left">CAUCUGGGCAACUGACUGAAC</td></tr><tr><td align="left">hsa-miR-3613-3p</td><td align="char">0.341514826</td><td align="left">263&#x02013;269</td><td align="left">ACAAAAAAAAAAGCCCAACCCUUC</td></tr><tr><td align="left">hsa-miR-5189-3p</td><td align="char">0.387056787</td><td align="left">582&#x02013;588</td><td align="left">UGCCAACCGUCAGAGCCCAGA</td></tr><tr><td align="left">hsa-miR-6808-3p</td><td align="char">0.466657576</td><td align="left">1103&#x02013;1109</td><td align="left">UGCCAACCGUCAGAGCCCAGA</td></tr></tbody></table></table-wrap></p></sec><sec id="sec3.2"><label>3.2</label><title>Serum/glucose starvation-induced enhanced binding of HNRNPA1 mRNA 3&#x002b9;UTR with miR-4745-5p, miR-6126, and miR-6798-5p</title><p id="p0100">TargetScanHuman 7.1 was used to identify miRNA binding regions on the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. miRNAs with increased binding during starvation were concentrated in the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (8 of 10 types at nt745&#x02013;nt1124), whereas miRNAs with decreased binding were almost equally distributed (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig2" ref-type="fig">Fig. 2</xref>A and B). Owing to the presence of &#x0201c;hot spots&#x0201d; (easily modified regions) in gene regulation, these eight miRNAs may play a central role in the serum/glucose starvation-induced regulation of hnRNP A1 expression. To examine whether the binding between the eight selected miRNAs and the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR can be detected under other experimental conditions, qPCR analysis was performed using pulled-down RNAs from co-transfected cells in the &#x003bb;N/boxB system. This revealed that the increased binding between full-length <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR and endogenous miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p was detected in serum/glucose-starved conditions (<xref rid="fig2" ref-type="fig">Fig. 2</xref>C). Total levels of miR-197-5p, miR-4734, miR-4745-5p, and miR-6831-5p did not increase under serum/glucose-starved conditions, whereas those of miR-4530, miR-6126, miR-6791-5p, and miR-6798-5p shows marginal increases. However the rates of elevation in miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p were not higher than the results of qPCR using pulled-down RNAs (<xref rid="fig2" ref-type="fig">Fig. 2</xref>C). These results suggested that the binding between miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p and <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR was confirmed.<fig id="fig2"><label>Fig. 2</label><caption><p><bold>Experimental screening of eight miRNA types for <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR binding.</bold> A. Expected binding map of candidate miRNAs on <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. The red highlighted section indicates the binding area of miRNAs where experiments were targeted. B. <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR sequences at nucleotides 745&#x02013;1124 where candidate miRNAs bind via their seed sequences (red letters). C. Un-transfected or co-transfected (5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR- and &#x003bb;N-Halo Tag-expression vectors) HeLa cells were incubated with complete or serum/glucose-starved culture media for 24&#x000a0;h, and total (un-transfected cells) and pulled-down (co-transfected cells) RNA were subjected to qPCR to detect the presence of miR-197-5p, miR-4530, miR-4734, miR-4745-5p, miR-6126, miR-6791-5p, miR-6798-5p, and miR-6831-5p. All experiments were performed in duplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test (comparison between the 10&#x000a0;% FBS and 0&#x000a0;% FBS/Glc (&#x02212;) groups).</p></caption><alt-text id="alttext0030">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></p><p id="p0105">Next, we constructed RNA-expression vectors expressing 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR bearing a mutation that interrupts binding to miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p (as indicated in <xref rid="fig3" ref-type="fig">Fig. 3</xref>A). qPCR analysis using these vectors revealed that the mutation at the miR-4745-5p, miR-6126, and miR-6798-5p binding sites in the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR lacked binding ability to corresponding miRNAs under serum/glucose-starved condition, whereas no effects were observed to other types of miRNAs (<xref rid="fig3" ref-type="fig">Fig. 3</xref>B). A binding assay was performed using synthesized miRNAs and their mutants, with biotin conjugated to the 3&#x002b9;-terminus (<xref rid="fig3" ref-type="fig">Fig. 3</xref>C). Cells were transfected with these synthesized oligos, lysed, and the complexes were pulled-down with streptavidin-conjugated magnetic beads. RNAs from each precipitant were subjected to qPCR for endogenous <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. As shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref>D, all transfected miRNAs were bound to endogenous <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR, and serum/glucose starvation potentiated their binding capacity in all miRNA-transfected groups. However, transfection with mutated miRNAs showed no binding, both in normal or serum/glucose-starved conditions. These results suggested that the binding of <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR to miR-4745-5p, miR-6126, and miR-6798-5p is driven under serum/glucose-starved conditions.<fig id="fig3"><label>Fig. 3</label><caption><p><bold>miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p are serum/glucose starvation-driven miRNAs for <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR.</bold> A. Diagram of 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR and associated mutants. B. Cotransfected (5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-expression vector or 5&#x000a0;&#x000d7;&#x000a0;boxB-fused mutant <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-expression vectors, and &#x003bb;N-Halo Tag-expression vector) HeLa cells were incubated with complete or serum/glucose-starved culture media for 24&#x000a0;h and pulled-down RNAs were subjected to qPCR for the presence of miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p. All experiments were performed in duplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test (comparison between the 10&#x000a0;% FBS and 0&#x000a0;% FBS/Glc (&#x02212;) groups); <italic>NS</italic>, not significant. C. The sequences of miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p, and their mutants. Mutated regions are shown in red letters. D. HeLa cells were transfected with biotinylated miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p, or their mutant counterparts. Transfected cells were lysed and pulled-down using streptavidin-conjugated magnetic beads. RNAs isolated from their precipitates were subjected to qPCR for the presence of <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (nt959&#x02013;1110). All experiments were performed in duplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; <italic>NC</italic>, universal negative control; <italic>B</italic>, biotinylated; &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;P&#x000a0;&#x0003c;&#x000a0;0.01&#x000a0;b&#x000a0;y a two-tailed Student's <italic>t</italic>-test (comparison to NC-transfected group).</p></caption><alt-text id="alttext0035">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec3.3"><label>3.3</label><title>miR-4745-5p and miR-6798-5p targets hnRNP A1 protein level via its 3&#x002b9;UTR</title><p id="p0110">We performed a luciferase reporter assay, qPCR following PAR-CLIP, qPCR, and immunoblotting to confirm and identify serum/glucose starvation-driven functional miRNAs. A luciferase reporter vector was used with <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-based genes fused downstream of the luciferase gene, and reporter activities were examined under normal or serum/glucose-starved conditions. The tested genes included the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (Luc-RNP 3&#x002b9;UTR) and mutants that could not bind miR-4734, miR-4745-5p, miR-6126, or miR-6798-5p (<xref rid="fig3" ref-type="fig">Fig. 3</xref>A) (Luc-RNP 3&#x002b9;UTR/miR-4734 mt, Luc-RNP 3&#x002b9;UTR/miR-4745 mt, Luc-RNP 3&#x002b9;UTR/miR-6126 mt, and Luc-RNP 3&#x002b9;UTR/miR-6798 mt, respectively; <xref rid="fig4" ref-type="fig">Fig. 4</xref>A). As expected, the reporter activity of Luc-RNP 3&#x002b9;UTR significantly decreased under serum/glucose starvation. The reporter activities of all mutant reporters showed no alteration compared to Luc-RNP 3&#x002b9;UTR under normal conditions. Noteworthy, those of all mutant reporters also did not decrease under serum/glucose-starved conditions (without any significance, <xref rid="fig4" ref-type="fig">Fig. 4</xref>B). Next, we tested effect of treatment of anti-miRNA for miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p on the reporter activity of Luc-RNP 3&#x002b9;UTR. The reporter activities of all anti-miRNA-treated cells showed no alteration compared to universal negative control-treated cells under normal conditions. The reporter activity was significantly decreased under serum/glucose starvation in universal negative control-treated cells. In contrast, treatment of anti-miRNA for miR-4745-5p, miR-6126, or miR-6798-5p apparently restored decrease of the reporter activity, whereas that of anti-miRNA for miR-4734 did not (<xref rid="fig4" ref-type="fig">Fig. 4</xref>C). To assess whether their miRNAs were preferentially recruited to the RNA-induced silencing complex (RISC) under serum/glucose-starved conditions, we performed a PAR-CLIP experiment using the anti-Ago2 antibody. Regardless of serum/glucose supplementation, miR-4745, miR-4745-5p, miR-6126, miR-6798-5p, and <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR (expected binding partner of examined miRNAs) were detected in RISC. Notably, serum/glucose starvation significantly increased miR-4745-5p and miR-6798-5p levels in RISCs (<xref rid="fig3" ref-type="fig">Fig. 3</xref>D). Finally, we examined whether miR-4745-5p and miR-6798-5p affect the endogenous hnRNP A1 expression level. The transient overexpression of miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p showed no change in mRNA levels (<xref rid="fig4" ref-type="fig">Fig. 4</xref>E), whereas an evident decrease in hnRNP A1 protein level was observed in miR-4745-5p- and miR-6798-5p-overexpressed cells, and a marginal decrease was found in miR-6126-overexpressed cells (<xref rid="fig4" ref-type="fig">Fig. 4</xref>F). In contrast, the transient transfection of mutated miRNAs did not alter the hnRNP A1 protein level (<xref rid="fig4" ref-type="fig">Fig. 4</xref>F). An experiment using anti-miRNAs further showed that inhibition of cellular miRNA by anti-miRNA for miR-4745-5p and miR-6798-5p attenuated serum/glucose starvation-induced loss of endogenous hnRNP A1, whereas these effects were not observed under normal conditions (<xref rid="fig4" ref-type="fig">Fig. 4</xref>G). These results indicated that miR-4745-5p and miR-6798-5p serve as serum/glucose starvation-driven miRNAs for hnRNP A1 protein expression.<fig id="fig4"><label>Fig. 4</label><caption><p><bold>Serum/glucose starvation-induced hnRNP A1 repression is mediated by miR-4745-5p and miR-6798-5p. A</bold>. Diagram of the Luc-RNP 3&#x002b9;UTR and its mutant. B. HeLa cells were co-transfected with internal pGL control and reporter vectors as indicated. Sequences of mutation are the same as shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref>A. After incubation with complete or serum/glucose-starved culture media for 24&#x000a0;h, relative luciferase activities were calculated by dividing the pRL value by the pGL value. All experiments were performed in duplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test (comparison between the 10&#x000a0;% FBS and 0&#x000a0;% FBS/Glc (&#x02212;) groups). C. HeLa cells were transfected with anti-miRNA for a universal negative control, miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p. After 24&#x000a0;h, cells were further co-transfected with an internal pGL control vector and the RNP 3&#x002b9;UTR reporter vector. After incubation with complete or serum/glucose-starved culture media for 24&#x000a0;h, relative luciferase activities were calculated as described above. All experiments were performed in triplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; <italic>NC</italic>, universal negative control, &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test (comparison between the 10&#x000a0;% FBS and 0&#x000a0;% FBS/Glc (&#x02212;) groups). D. Lysates from normal or serum/glucose-starved cells were treated with the anti-Ago2 antibody or isotype IgG and precipitated with protein G-conjugated magnetic beads. RNAs isolated from their immune precipitates were subjected to qPCR for the presence of miR-4734, miR-4745-5p, miR-6126, miR-6798-5p, and <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR. All experiments were performed in duplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test (comparison between the IgG- and anti-Ago2&#x02013;treated groups, except the comparison indicated by the line). E. HeLa cells were transfected with empty- or miRNA-expression vectors for miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p for 48&#x000a0;h. Total RNA from these cells was subjected to qPCR for <italic>HNRNPA1</italic> mRNA. All experiments were performed in triplicate. <italic>Columns</italic>, mean values (<italic>n</italic>&#x000a0;=&#x000a0;3); <italic>bars</italic>, SD; <italic>OE</italic>, overexpression. F. HeLa cells were transfected with empty- or miRNA-expression vectors for miR-4734, miR-4745-5p, miR-6126, miR-6798-5p, along with a universal negative control, and mutated miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p for 48&#x000a0;h. Mutation sequences are the same as those in <xref rid="fig3" ref-type="fig">Fig. 3</xref>C. Lysates from these cells were used in immunoblotting for hnRNP A1. Pictures are representative of four independent experiments. <italic>OE</italic>, overexpression; <italic>NC</italic>, universal negative control. G. HeLa cells were transfected with an anti-miRNA for miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p. After 24&#x000a0;h, cells were incubated with complete or serum/glucose-starved culture media for 24&#x000a0;h, lysed, and immunoblotted for hnRNP A1. Pictures are representative of two independent experiments. <italic>NC</italic>, universal negative control.</p></caption><alt-text id="alttext0040">Fig. 4</alt-text><graphic xlink:href="gr4"/></fig></p></sec><sec id="sec3.4"><label>3.4</label><title>hnRNP A1-dependent effect of miR-4745-5p and miR-6798-5p on cellular growth in HeLa cells</title><p id="p0115">To clarify whether miR-4745-5p and miR-6798-5p are functional miRNAs for cellular growth via hnRNP A1 repression, five types of transiently transfected cells overexpressing miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p were subjected to a WST-8 assay. As shown in <xref rid="fig5" ref-type="fig">Fig. 5</xref>A, the increase in cell number at 48&#x000a0;h after incubation was significantly lower in miR-4745-5p- and miR-6798-5p-overexpressing cells than that in empty vector-transfected cells. However, miR-4734- and miR-6126- overexpressing cells showed no difference in cell number increase. In contrast, cells transfected with miRNA mutants whose sequences are shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref>C, exhibited no change in growth rate (<xref rid="fig5" ref-type="fig">Fig. 5</xref>B). Cells were subsequently transfected with anti-miRNA for miR-4745-5p and miR-6798-5p and incubated in either complete or serum/glucose-starved media. Under incubation in complete media, cell number increase rates at 48&#x000a0;h after incubation were marginally higher (yet not significantly) in cells transfected with anti-miRNA for miR-4745-5p and miR-6798-5p. Consequently, transfection with anti-miRNA for miR-4745-5p and miR-6798-5p significantly promoted cell number increase at 48&#x000a0;h serum/glucose-starved conditions (<xref rid="fig5" ref-type="fig">Fig. 5</xref>C). Immunoblotting confirmed that the expression status of hnRNP A1 was consistent with <xref rid="fig4" ref-type="fig">Fig. 4</xref>G (<xref rid="fig5" ref-type="fig">Fig. 5</xref>C), suggesting that the growth promotion by anti-miRNA for miR-4745-5p and miR-6798-5p is due to the restoration of hnRNP A1. In rescue experiments, co-transfection with miR-4745-5p and miR-6798-5p expression vectors and anti-miRNA for miR-4745-5p and miR-6798-5p was performed. In empty vector-transfected HeLa cells, anti-miRNA for miR-4745-5p and miR-6798-5p had no effect on cell number increase rates at 48&#x000a0;h. HeLa cells transfected with anti-miRNA negative control plus miR-4745-5p and miR-6798-5p expression vectors were showed a significant decrease in cell number increase at 48&#x000a0;h, whereas transfection with anti-miRNA for miR-4745-5p and miR-6798-5p plus expression vectors of miR-4745-5p and miR-6798-5p significantly restored cell number increase at 48&#x000a0;h (<xref rid="fig5" ref-type="fig">Fig. 5</xref>D and E). Finally, we examined the effect of hnRNP A1 overexpression on cellular growth in miR-4745-5p- and miR-6798-5p-overexpressing HeLa cells. As in previous results, miR-4745-5p- and miR-6798-5p-overexpressing HeLa cells showed a significant decrease in cell number increase at 48&#x000a0;h than in empty vector-transfected HeLa cells. When hnRNP A1-HA were overexpressed, the cell number increase at 48&#x000a0;h was significantly higher in all cell lines (those transfected with an empty vector, miR-4745-5p-expression vector, and miR-6798-5p-expression vector). Additionally, immunoblotting indicated successful expression of hnRNP A1-HA (<xref rid="fig5" ref-type="fig">Fig. 5</xref>F). These results indicated that hnRNP A1 is partially involved in growth suppression by miR-4745-5p and miR-6798-5p.<fig id="fig5"><label>Fig. 5</label><caption><p><bold>miR-4745-5p and miR-6798-5p suppress cell growth in an hnRNP A1-dependent manner.</bold> A. HeLa cells transfected with empty- or miRNA-expression vectors for miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p were incubated in complete media and cell growth was measured using the WST-8 assay. The A<sub>450</sub> value at 0&#x000a0;h was designated as 100&#x000a0;% in the WST-8 assay, and the relative percentages at 24 and 48&#x000a0;h are shown. All experiments were performed in triplicate. <italic>Symbols</italic>, mean percentages (<italic>n</italic>&#x000a0;=&#x000a0;6); <italic>bars</italic>, SD; <italic>OE</italic>, overexpression; &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test. B. HeLa cells transfected with universal negative control, mutated miR-4734, miR-4745-5p, miR-6126, and miR-6798-5p were subjected to the WST-8 assay as in <xref rid="fig5" ref-type="fig">Fig. 5</xref>A. All experiments were performed in triplicate. <italic>Symbols</italic>, mean percentages (<italic>n</italic>&#x000a0;=&#x000a0;6); <italic>bars</italic>, SD; <italic>NC</italic>, universal negative control. C. HeLa cells transfected with the universal negative control, an anti-miRNA for miR-4745-5p, and miR-6798-5p were incubated in complete or serum/glucose-starved culture media. Cell growth after 48&#x000a0;h was measured using the WST-8 assay. The A<sub>450</sub> value at 0&#x000a0;h was designated as 100&#x000a0;% in WST-8 assay, and the relative percentages at 48&#x000a0;h are shown. All experiments were performed in duplicate. <italic>Columns</italic>, mean percentages (<italic>n</italic>&#x000a0;=&#x000a0;6); <italic>bars</italic>, SD; <italic>NC</italic>, universal negative control; &#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.05 using a two-tailed Student's <italic>t</italic>-test. In parallel, these cells were subjected to immunoblotting for hnRNP A1. Pictures are representative of two independent experiments. <italic>NC</italic>, universal negative control. D-E. HeLa cells co-transfected with empty vector plus universal negative control, anti-miRNA for miR-4745-5p, or anti-miRNA for miR-6798-5p, miRNA-expression vectors for miR-4745-5p plus universal negative control or anti-miRNA for miR-4745-5p, and miRNA-expression vectors for miR-6798-5p plus universal negative control or anti-miRNA for miR-6798-5p were incubated in complete media, and cell growth after 48&#x000a0;h was measured using the WST-8 assay. The A<sub>450</sub> value at 0&#x000a0;h was designated as 100&#x000a0;% in the WST-8 assay, and the relative percentages at 48&#x000a0;h are shown. All experiments were performed in duplicate. <italic>Columns</italic>, mean percentages (<italic>n</italic>&#x000a0;=&#x000a0;6); <italic>bars</italic>, SD; <italic>NC</italic>, universal negative control; <italic>OE</italic>, overexpression; &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test. F. HeLa cells co-transfected with the empty vector plus mock or hnRNP A1-HA expression vector, miRNA-expression vectors for miR-4745-5p plus mock or hnRNP A1-HA expression vector, and miRNA-expression vectors for miR-6798-5p plus mock or hnRNP A1-HA expression vector were incubated in complete media, and cell growth was measured after 48&#x000a0;h using the WST-8 assay. The A<sub>450</sub> value at 0&#x000a0;h was designated as 100&#x000a0;% in the WST-8 assay, and the relative percentages at 48&#x000a0;h are shown. All experiments were performed in triplicate. <italic>Columns</italic>, mean percentages (<italic>n</italic>&#x000a0;=&#x000a0;6); <italic>bars</italic>, SD; <italic>OE</italic>, overexpression; &#x02217;P&#x000a0;&#x0003c;&#x000a0;0.05 and &#x02217;&#x02217;<italic>P&#x000a0;&#x0003c;</italic>&#x000a0;0.01 using a two-tailed Student's <italic>t</italic>-test. In parallel, these cells were subjected to immunoblotting for HA and hnRNP A1. Pictures are representative of two independent experiments. <italic>OE</italic>, overexpression.</p></caption><alt-text id="alttext0045">Fig. 5</alt-text><graphic xlink:href="gr5"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0120">In bacteriophage &#x003bb;, transcriptional termination is suppressed via a multifactor complex that includes the N peptide and boxB sequence at the <italic>nut</italic> site, facilitating in bypassing the downstream terminator region [<xref rid="bib26" ref-type="bibr">26</xref>,<xref rid="bib27" ref-type="bibr">27</xref>]. Our &#x003bb;N/boxB system leverages the specific interaction between the &#x003bb; phage-derived N peptide and the boxB RNA sequence [<xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>], an interaction that can be used to tether &#x003bb;N-fused transcription factors to the boxB-inserted promoter region [<xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>]. However, we considered that this strong, specific interaction could also serve us a tool for detecting molecules bound to &#x0201c;desired RNA&#x0201d; sequences. Hence, to establish a novel identification method for RNA-binding factors using this interaction, we adapted a pulldown-based procedure, allowing for isolation, purification, and/or concentration steps necessary for comprehensive analysis, such as next-generation sequencing or microarrays. Notably, serum/glucose starvation reduces hnRNP A1 protein levels without altering mRNA levels, suggesting posttranscriptional regulation involving miRNAs [<xref rid="bib18" ref-type="bibr">18</xref>]. This background motivated us to determine the serum/glucose starvation-driven miRNAs for hnRNP A1 by using the &#x003bb;N/boxB system.</p><p id="p0125">Using co-transfection with Halo tag-fused &#x003bb;N- and 5&#x000a0;&#x000d7;&#x000a0;boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR-expression vectors and subsequent pulldown, we performed miRNA microarray analysis to identify serum/glucose starvation-driven miRNAs for hnRNP A1. Eight candidate miRNAs were initially selected based on information from miRNA databases. Subsequent binding analyses with intact or mutant constructs and biotinylated miRNAs narrowed down the candidates to miR-4745-5p, miR-6126, and miR-6798-5p. Reporter assays, qPCR, PAR-CLIP/qPCR, and immunoblotting were conducted to identify functional miRNAs that regulate hnRNP A1 protein expression. These assays revealed that miR-4745-5p and miR-6798-5p act as serum/glucose starvation-driven functional miRNAs that downregulate protein levels. However, pretreatment with anti-miRNA for these candidates only partially recovered hnRNP A1 protein loss by serum/glucose starvation, suggesting that miR-4745-5p and miR-6798-5p also targets other genes and <italic>HNRNPA1</italic>, diluting their specific effect on <italic>HNRNPA1</italic> mRNA.</p><p id="p0130">As several reports indicate that hnRNP A1 promotes cancer cell growth [<xref rid="bib12" ref-type="bibr">12</xref>,<xref rid="bib14" ref-type="bibr">14</xref>,<xref rid="bib34" ref-type="bibr">34</xref>], we tested whether miR-4745-5p and miR-6798-5p for effects on cancer cell growth via an hnRNP A1-dependent manner. As expected, miR-4745-5p and miR-6798-5p overexpression significantly reduced cellular growth, whereas mutated versions did not. Anti-miRNAs for miR-4745-5p and miR-6798-5p increased cellular growth under serum/glucose-starved conditions and reversed their growth suppressing effects. Furthermore, re-expression of hnRNP A1 also reversed miR-4745-5p- and miR-6798-5p-mediated growth suppression, suggesting that they regulate hnRNP A1-associated cellular growth. Using TargetScanHuman 7.1, nine growth-related genes (<italic>IGF1</italic>, <italic>IGF1R</italic>, <italic>IGF2R</italic>, <italic>IGFBP4</italic>, <italic>IGFBP5</italic>, <italic>IGF2BP1</italic>, <italic>FGF11</italic>, <italic>FGF19</italic>, and <italic>TGFA</italic>) were identified as common targets of miR-4745-5p and miR-6798-5p [<xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>]. The anti-miRNA's effect may involve a combination of influence on <italic>HNRNPA1</italic> gene and other target genes. This hypothesis is credible as anti-miRNAs incompletely restored hnRNP A1 protein expression, suggesting that anti-miRNAs also acted on additional gene targets. Currently, only four studies on miR-4745-5p and miR-6798-5p have been published [<xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>, <xref rid="bib46" ref-type="bibr">[46]</xref>], emphasizing the need for detailed investigation, especially in cancer cells. Moreover, the cellular status-dependent mechanism of miRNA recruitment to the mRNA 3&#x002b9;UTR region is unclear and warrants further investigation to clarify how serum/glucose starvation enhances binding between specific miRNAs and <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR.</p><p id="p0135">The &#x003bb;N/boxB system was used to identify prey miRNAs using the boxB-fused <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR as bait. This system can be applied in various of detection methods to identify molecules specifically bound to a &#x0201c;desired RNA&#x0201d; sequence. For example of use, it is being used to detect novel proteins bound to the <italic>HNRNPA1</italic> mRNA 3&#x002b9;UTR by the &#x003bb;N/boxB system via silver staining, SDS-PAGE, and liquid chromatography/mass spectrometry. Furthermore, the &#x003bb;N/boxB system is being developed to identify regulatory factors for pre-mRNA splicing, using a pre-mRNA sequence across the intron&#x02013;exon boundary region as bait. This system is also applicable for binding analysis of &#x0201c;desired RNA&#x0201d; or for identifying binding motifs of RNA-interacting molecules. Another advantage of the &#x003bb;N/boxB system is that its results likely reflect intracellular reactions owing to its basis in cellular co-expression. This feature of the &#x003bb;N/boxB system helps minimize artificial results, making it a reliable method.</p></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p id="p0140">The &#x003bb;N/boxB system enabled the identification of miR-4745-5p and miR-6798-5p as serum/glucose starvation-driven miRNAs targeting hnRNP A1. Detailed functional analysis of miR-4745-5p and miR-6798-5p is crucial for understanding the biological significance of hnRNP A1 protein depletion in serum/glucose-deficient lesions, such as deep tumor masses. Furthermore, the &#x003bb;N/boxB system, may, in principle, use any &#x0201c;desired RNA&#x0201d; sequence as bait, making it a valuable tool for analyzing RNA-interacting factors, regardless of whether they are DNA, RNA, or proteins. Understanding how serum/glucose starvation induces specific miRNA activation is a critical area for future research.</p></sec><sec id="sec6"><title>CRediT authorship contribution statement</title><p id="p0145"><bold>Tetsuyuki Takahashi:</bold> Writing &#x02013; original draft, Validation, Supervision, Methodology, Investigation, Funding acquisition, Data curation, Conceptualization. <bold>Mai Funamura:</bold> Validation, Data curation. <bold>Shun Wakai:</bold> Validation, Data curation. <bold>Takao Hijikata:</bold> Writing &#x02013; review &#x00026; editing, Supervision, Conceptualization.</p></sec><sec sec-type="data-availability" id="sec7"><title>Data availability statement</title><p id="p0150">The data that support the findings of this study are available upon request from the corresponding author.</p></sec><sec id="sec8"><title>Funding</title><p id="p0155">This study was supported by JSPS KAKENHI (grant number JP21K06538) and a grant from <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100019640</institution-id><institution>Musashino University</institution></institution-wrap></funding-source> to TT.</p></sec><sec sec-type="COI-statement" id="coi0010"><title>Declaration of competing interest</title><p id="p0160">The authors have declared that no competing interests exist.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Geuens</surname><given-names>T.</given-names></name><name><surname>Bouhy</surname><given-names>D.</given-names></name><name><surname>Timmerman</surname><given-names>V.</given-names></name></person-group><article-title>The hnRNP family: insights into their role in health and disease</article-title><source>Hum. Genet.</source><volume>135</volume><year>2016</year><fpage>851</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1007/s00439-016-1683-5</pub-id><pub-id pub-id-type="pmid">27215579</pub-id>
</element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Qu</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing</article-title><source>Biochim. Biophys. Acta Gene Regul. Mech.</source><volume>1865</volume><year>2022</year><object-id pub-id-type="publisher-id">194875</object-id><pub-id pub-id-type="doi">10.1016/j.bbagrm.2022.194875</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Jo</surname><given-names>D.S.</given-names></name><name><surname>Jo</surname><given-names>Y.K.</given-names></name><name><surname>Shin</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.B.</given-names></name><etal/></person-group><article-title>Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells</article-title><source>Biochim. Biophys. Acta</source><volume>1849</volume><year>2015</year><fpage>1423</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2015.10.017</pub-id><pub-id pub-id-type="pmid">26518267</pub-id>
</element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Izaurralde</surname><given-names>E.</given-names></name><name><surname>Jarmolowski</surname><given-names>A.</given-names></name><name><surname>Beisel</surname><given-names>C.</given-names></name><name><surname>Mattaj</surname><given-names>I.W.</given-names></name><name><surname>Dreyfuss</surname><given-names>G.</given-names></name><name><surname>Fischer</surname><given-names>U.</given-names></name></person-group><article-title>A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export</article-title><source>J. Cell Biol.</source><volume>137</volume><year>1997</year><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1083/jcb.137.1.27</pub-id><pub-id pub-id-type="pmid">9105034</pub-id>
</element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Dallaire</surname><given-names>F.</given-names></name><name><surname>Dupuis</surname><given-names>S.</given-names></name><name><surname>Fiset</surname><given-names>S.</given-names></name><name><surname>Chabot</surname><given-names>Bs</given-names></name></person-group><article-title>Heterogenous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro</article-title><source>J. Biol. Chem.</source><volume>275</volume><year>2000</year><fpage>14509</fpage><lpage>14516</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.19.14509</pub-id><pub-id pub-id-type="pmid">10799534</pub-id>
</element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>B.J.</given-names></name><name><surname>Nagy</surname><given-names>E.</given-names></name><name><surname>Malter</surname><given-names>J.S.</given-names></name><name><surname>Arrick</surname><given-names>B.A.</given-names></name><name><surname>Rigby</surname><given-names>W.F.</given-names></name></person-group><article-title>Association of heterogenous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences</article-title><source>J. Biol. Chem.</source><volume>268</volume><year>1993</year><fpage>8881</fpage><lpage>8887</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)52955-0</pub-id><pub-id pub-id-type="pmid">8473331</pub-id>
</element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>N.</given-names></name><name><surname>Lin</surname><given-names>H.C.</given-names></name><name><surname>Morgan</surname><given-names>C.E.</given-names></name><name><surname>Harris</surname><given-names>M.E.</given-names></name><name><surname>Tolbert</surname><given-names>B.S.</given-names></name></person-group><article-title>Rules of RNA specificity of hnRNP A1 revealed by global and quantitative analysis of its affinity distribution</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>114</volume><year>2017</year><fpage>2206</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1073/pnas.1616371114</pub-id><pub-id pub-id-type="pmid">28193894</pub-id>
</element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>N.C.</given-names></name><name><surname>Wang</surname><given-names>Y.D.</given-names></name><name><surname>Scarborough</surname><given-names>E.A.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name><name><surname>Diaz</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS</article-title><source>Nature</source><volume>495</volume><year>2013</year><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/nature11922</pub-id><pub-id pub-id-type="pmid">23455423</pub-id>
</element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>H.</given-names></name><name><surname>Ishiura</surname><given-names>H.</given-names></name><name><surname>Mitsui</surname><given-names>J.</given-names></name><name><surname>Date</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Matsukawa</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation</article-title><source>Neurobiol. Aging</source><volume>61</volume><year>2018</year><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.08.030</pub-id><comment>255.e9&#x02013;255.e16</comment></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Berson</surname><given-names>A.</given-names></name><name><surname>Barbash</surname><given-names>S.</given-names></name><name><surname>Shaltiel</surname><given-names>G.</given-names></name><name><surname>Goll</surname><given-names>Y.</given-names></name><name><surname>Hanin</surname><given-names>G.</given-names></name><name><surname>Greenberg</surname><given-names>G.H.</given-names></name><etal/></person-group><article-title>Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice</article-title><source>EMBO Mol. Med.</source><volume>4</volume><year>2012</year><fpage>730</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1002/emmm.201100995</pub-id><pub-id pub-id-type="pmid">22628224</pub-id>
</element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Shirendeb</surname><given-names>U.P.</given-names></name><name><surname>Calkins</surname><given-names>M.J.</given-names></name><name><surname>Manczak</surname><given-names>M.</given-names></name><name><surname>Anekonda</surname><given-names>V.</given-names></name><name><surname>Dufour</surname><given-names>G.</given-names></name><name><surname>McBride</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease</article-title><source>Hum. Mol. Genet.</source><volume>21</volume><year>2012</year><fpage>406</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr475</pub-id><pub-id pub-id-type="pmid">21997870</pub-id>
</element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z.J.</given-names></name><name><surname>Dai</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>S.L.</given-names></name><name><surname>Fu</surname><given-names>Z.T.</given-names></name><name><surname>Zhao</surname><given-names>Y.M.</given-names></name><name><surname>Shi</surname><given-names>Y.H.</given-names></name><etal/></person-group><article-title>Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma</article-title><source>Int. J. Cancer</source><volume>132</volume><year>2013</year><fpage>1080</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1002/ijc.27742</pub-id><pub-id pub-id-type="pmid">22821376</pub-id>
</element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Ushigome</surname><given-names>M.</given-names></name><name><surname>Ubagai</surname><given-names>T.</given-names></name><name><surname>Fukuda</surname><given-names>H.</given-names></name><name><surname>Tsuchiya</surname><given-names>N.</given-names></name><name><surname>Sugimura</surname><given-names>T.</given-names></name><name><surname>Takatsuka</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers</article-title><source>Int. J. Oncol.</source><volume>26</volume><year>2005</year><fpage>635</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.3892/ijo.26.3.635</pub-id><pub-id pub-id-type="pmid">15703818</pub-id>
</element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>R.</given-names></name><name><surname>Fan</surname><given-names>M.</given-names></name></person-group><article-title>Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation</article-title><source>J. Cell. Physiol.</source><volume>230</volume><year>2015</year><fpage>2252</fpage><lpage>2261</lpage><pub-id pub-id-type="doi">10.1002/jcp.24956</pub-id><pub-id pub-id-type="pmid">25752295</pub-id>
</element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Boukakis</surname><given-names>G.</given-names></name><name><surname>Patrinou-Georgoula</surname><given-names>M.</given-names></name><name><surname>Lekarakou</surname><given-names>M.</given-names></name><name><surname>Valavanis</surname><given-names>C.</given-names></name><name><surname>Guialis</surname><given-names>A.</given-names></name></person-group><article-title>Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues</article-title><source>BMC Cancer</source><volume>10</volume><year>2010</year><fpage>434</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-10-434</pub-id><pub-id pub-id-type="pmid">20716340</pub-id>
</element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Xiang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><etal/></person-group><article-title>High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer</article-title><source>Oncol. Rep.</source><volume>39</volume><year>2018</year><fpage>1693</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6273</pub-id><pub-id pub-id-type="pmid">29484423</pub-id>
</element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Iervolino</surname><given-names>A.</given-names></name><name><surname>Santilli</surname><given-names>G.</given-names></name><name><surname>Trotta</surname><given-names>R.</given-names></name><name><surname>Guerzoni</surname><given-names>C.</given-names></name><name><surname>Cesi</surname><given-names>V.</given-names></name><name><surname>Bergamaschi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis</article-title><source>Mol. Cell Biol.</source><volume>22</volume><year>2002</year><fpage>2255</fpage><lpage>2266</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.7.2255-2266.2002</pub-id><pub-id pub-id-type="pmid">11884611</pub-id>
</element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Ando</surname><given-names>Y.</given-names></name><name><surname>Ichikawa</surname><given-names>H.</given-names></name><name><surname>Tsuneyama</surname><given-names>K.</given-names></name><name><surname>Hijikata</surname><given-names>T.</given-names></name></person-group><article-title>Serum/glucose starvation strikingly reduces heterogenous nuclear ribonucleoprotein A1 protein and its target, cyclin D1</article-title><source>FEBS J.</source><volume>290</volume><year>2023</year><fpage>4126</fpage><lpage>4144</lpage><pub-id pub-id-type="doi">10.1111/febs.16802</pub-id><pub-id pub-id-type="pmid">37095740</pub-id>
</element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>S.</given-names></name><name><surname>Izaurralde</surname><given-names>E.</given-names></name></person-group><article-title>Towards a molecular understanding of microRNA-mediated gene silencing</article-title><source>Nat. Rev. Genet.</source><volume>16</volume><year>2015</year><fpage>421</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1038/nrg3965</pub-id><pub-id pub-id-type="pmid">26077373</pub-id>
</element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>T.</given-names></name><name><surname>Varshney</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Shekhar</surname><given-names>R.</given-names></name><etal/></person-group><article-title>MicroRNA-874-mediated inhibition of the major G<sub>1</sub>/S phase cyclin, CCNE1, is lost in osteosarcomas</article-title><source>J. Biol. Chem.</source><volume>292</volume><year>2017</year><fpage>21264</fpage><lpage>21281</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.808287</pub-id><pub-id pub-id-type="pmid">29109143</pub-id>
</element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Ni</surname><given-names>P.</given-names></name><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with microRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop</article-title><source>Nucleic Acids Res.</source><volume>39</volume><year>2011</year><fpage>6440</fpage><lpage>6455</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr302</pub-id><pub-id pub-id-type="pmid">21572107</pub-id>
</element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Emde</surname><given-names>A.</given-names></name><name><surname>Eitan</surname><given-names>C.</given-names></name><name><surname>Liou</surname><given-names>L.L.</given-names></name><name><surname>Libby</surname><given-names>R.T.</given-names></name><name><surname>Rivkin</surname><given-names>N.</given-names></name><name><surname>Magen</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS</article-title><source>EMBO J.</source><volume>34</volume><year>2015</year><fpage>2633</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.15252/embj.201490493</pub-id><pub-id pub-id-type="pmid">26330466</pub-id>
</element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Luna</surname><given-names>C.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Epstein</surname><given-names>D.L.</given-names></name><name><surname>Gonzalez</surname><given-names>P.</given-names></name></person-group><article-title>Alterations in microRNA expression in stress-induced cellular senescence</article-title><source>Mech. Ageing Dev.</source><volume>130</volume><year>2009</year><fpage>731</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2009.09.002</pub-id><pub-id pub-id-type="pmid">19782699</pub-id>
</element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Rahmani</surname><given-names>M.</given-names></name><name><surname>Mohammadnia-Afrouzi</surname><given-names>M.</given-names></name><name><surname>Nouri</surname><given-names>H.R.</given-names></name><name><surname>Fattahi</surname><given-names>S.</given-names></name><name><surname>Akhavan-Niaki</surname><given-names>H.</given-names></name><name><surname>Mostafazadeh</surname><given-names>A.</given-names></name></person-group><article-title>Human PBMCs fight or flight response to starvation stress: increased T-reg, FOXP3, and TGF-&#x003b2;1 with decreased miR-21 and constant miR-181c levels</article-title><source>Biomed. Pharmacother.</source><volume>108</volume><year>2018</year><fpage>1404</fpage><lpage>1411</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.09.163</pub-id><pub-id pub-id-type="pmid">30453448</pub-id>
</element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Ichikawa</surname><given-names>H.</given-names></name><name><surname>Okayama</surname><given-names>Y.</given-names></name><name><surname>Seki</surname><given-names>M.</given-names></name><name><surname>Hijikata</surname><given-names>T.</given-names></name></person-group><article-title>SV40 miR-S1 and cellular miR-1266 sequester each other from their targets, enhancing telomerase activity and viral expression</article-title><source>Non-coding RNA</source><volume>8</volume><year>2022</year><fpage>57</fpage><pub-id pub-id-type="doi">10.3390/ncrna8040057</pub-id><pub-id pub-id-type="pmid">36005825</pub-id>
</element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Greenblatt</surname><given-names>J.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name><name><surname>Mason</surname><given-names>S.W.</given-names></name></person-group><article-title>Transcriptional antitermination</article-title><source>Nature</source><volume>364</volume><year>1993</year><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1038/364401a0</pub-id><pub-id pub-id-type="pmid">8332211</pub-id>
</element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>M.</given-names></name><name><surname>Court</surname><given-names>D.</given-names></name><name><surname>Shimatake</surname><given-names>H.</given-names></name><name><surname>Wulff</surname><given-names>D.L.</given-names></name></person-group><article-title>The relationship between function and DNA sequence in an intercistronic regulatory region in phage lambda</article-title><source>Nature</source><volume>272</volume><year>1978</year><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/272414a0</pub-id><pub-id pub-id-type="pmid">634366</pub-id>
</element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>S.</given-names></name><name><surname>Hung</surname><given-names>S.C.</given-names></name><name><surname>Stuart</surname><given-names>A.C.</given-names></name><name><surname>Palmer</surname><given-names>A.G.</given-names><suffix>3rd</suffix></name><name><surname>Garcia-Mena</surname><given-names>J.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Interaction between the phage HK022 Nun protein and the nut RNA of phage lambda</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>92</volume><year>1995</year><fpage>12131</fpage><lpage>12135</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.26.12131</pub-id><pub-id pub-id-type="pmid">8618858</pub-id>
</element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Van Gilst</surname><given-names>M.R.</given-names></name><name><surname>von Hippel</surname><given-names>P.H.</given-names></name></person-group><article-title>Assembly of the N-dependent antitermination complex of phage lambda: NusA and RNA bind independently to different unfolded domains of the N protein</article-title><source>J. Mol. Biol.</source><volume>274</volume><year>1997</year><fpage>160</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1997.1389</pub-id><pub-id pub-id-type="pmid">9398524</pub-id>
</element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Legault</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mogridge</surname><given-names>J.</given-names></name><name><surname>Kay</surname><given-names>L.E.</given-names></name><name><surname>Greenblatt</surname><given-names>J.</given-names></name></person-group><article-title>NMR structure of the bacteriophage lambda N peptide/boxB RNA complex: Recognition of a GNRA fold by an arginine-rich motif</article-title><source>Cell</source><volume>93</volume><year>1998</year><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81579-2</pub-id><pub-id pub-id-type="pmid">9568720</pub-id>
</element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>De Gregorio</surname><given-names>E.</given-names></name><name><surname>Baron</surname><given-names>J.</given-names></name><name><surname>Preiss</surname><given-names>T.</given-names></name><name><surname>Hentze</surname><given-names>M.W.</given-names></name></person-group><article-title>Tethered-function analysis reveals that eIF4E can recruit ribosomes independent of its binding to the cap structure</article-title><source>RNA</source><volume>7</volume><year>2001</year><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1017/s1355838201000577</pub-id><pub-id pub-id-type="pmid">11214172</pub-id>
</element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Baron-Benhamou</surname><given-names>J.</given-names></name><name><surname>Gehring</surname><given-names>N.H.</given-names></name><name><surname>Kulozik</surname><given-names>A.E.</given-names></name><name><surname>Hentze</surname><given-names>M.W.</given-names></name></person-group><article-title>Using the lambda peptide to tether proteins to RNAs</article-title><source>Methods Mol. Biol.</source><volume>257</volume><year>2004</year><fpage>135</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1385/1-59259-750-5:135</pub-id><pub-id pub-id-type="pmid">14770003</pub-id>
</element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Kunz</surname><given-names>J.B.</given-names></name><name><surname>Neu-Yilik</surname><given-names>G.</given-names></name><name><surname>Hentze</surname><given-names>M.W.</given-names></name><name><surname>Kulozik</surname><given-names>A.E.</given-names></name><name><surname>Gehring</surname><given-names>N.H.</given-names></name></person-group><article-title>Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation</article-title><source>RNA</source><volume>12</volume><year>2006</year><fpage>1015</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1261/rna.12506</pub-id><pub-id pub-id-type="pmid">16601204</pub-id>
</element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>H.G.</given-names></name><name><surname>Jung</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>N.</given-names></name><name><surname>Seo</surname><given-names>J.Y.</given-names></name><name><surname>Kim</surname><given-names>S.W.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name><etal/></person-group><article-title>HNRNP A1 promotes lung cancer cell proliferation by modulating VRK1 translation</article-title><source>Int. J. Mol. Sci.</source><volume>22</volume><year>2021</year><fpage>5506</fpage><pub-id pub-id-type="doi">10.3390/ijms22115506</pub-id><pub-id pub-id-type="pmid">34071140</pub-id>
</element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Peyrat</surname><given-names>J.P.</given-names></name><name><surname>Bonneterre</surname><given-names>J.</given-names></name><name><surname>Vennin</surname><given-names>P.H.</given-names></name><name><surname>Jammes</surname><given-names>H.</given-names></name><name><surname>Beuscart</surname><given-names>R.</given-names></name><name><surname>Hecquet</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors</article-title><source>J. Steroid Biochem. Mol. Biol.</source><volume>37</volume><year>1990</year><fpage>823</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1016/0960-0760(90)90426-l</pub-id><pub-id pub-id-type="pmid">2178365</pub-id>
</element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>L.K.</given-names></name><name><surname>Westwood</surname><given-names>M.</given-names></name></person-group><article-title>Biology and significance of signaling pathways activated by IGF-II</article-title><source>Growth Factors</source><volume>30</volume><year>2012</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3109/08977194.2011.640325</pub-id><pub-id pub-id-type="pmid">22136428</pub-id>
</element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Durai</surname><given-names>R.</given-names></name><name><surname>Davies</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>S.Y.</given-names></name><name><surname>Seifalian</surname><given-names>A.</given-names></name><name><surname>Goldspink</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Biology of insulin-like growth factor binding protein-4 and its role in cancer</article-title><source>Int. J. Oncol.</source><volume>28</volume><year>2006</year><fpage>1317</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.3892/ijo.28.6.1317</pub-id><comment>(review)</comment><pub-id pub-id-type="pmid">16685432</pub-id>
</element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Dittmer</surname><given-names>J.</given-names></name></person-group><article-title>Biological effects and regulation of IGFBP5 in breast cancer</article-title><source>Front. Endocrinol.</source><volume>13</volume><year>2022</year><object-id pub-id-type="publisher-id">983793</object-id><pub-id pub-id-type="doi">10.3389/fendo.2022.983793</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name></person-group><article-title>Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer</article-title><source>J. Hematol. Oncol.</source><volume>11</volume><year>2018</year><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/s13045-018-0628-y</pub-id><pub-id pub-id-type="pmid">29954406</pub-id>
</element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Ke</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway</article-title><source>J. Transl. Med.</source><volume>19</volume><year>2021</year><fpage>353</fpage><pub-id pub-id-type="doi">10.1186/s12967-021-03018-7</pub-id><pub-id pub-id-type="pmid">34404435</pub-id>
</element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>M.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Cui</surname><given-names>R.</given-names></name></person-group><article-title>Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression</article-title><source>Front. Cell Dev. Biol.</source><volume>8</volume><year>2020</year><fpage>95</fpage><pub-id pub-id-type="doi">10.3389/fcell.2020.00095</pub-id><pub-id pub-id-type="pmid">32154250</pub-id>
</element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>J.</given-names></name><name><surname>Yeh</surname><given-names>Y.C.</given-names></name></person-group><article-title>Transforming growth factor-alpha and human cancer</article-title><source>Biomed. Pharmacother.</source><volume>43</volume><year>1989</year><fpage>651</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/0753-3322(89)90083-8</pub-id><pub-id pub-id-type="pmid">2696564</pub-id>
</element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Shirakami</surname><given-names>Y.</given-names></name><name><surname>Iwashita</surname><given-names>T.</given-names></name><name><surname>Uemura</surname><given-names>S.</given-names></name><name><surname>Imai</surname><given-names>H.</given-names></name><name><surname>Murase</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>M.</given-names></name></person-group><article-title>Micro-RNA analysis of pancreatic cyst fluid for diagnosing malignant transformation of intraductal papillary mucinous neoplasm by comparing intraductal papillary mucinous adenoma and carcinoma</article-title><source>J. Clin. Med.</source><volume>10</volume><year>2021</year><fpage>2249</fpage><pub-id pub-id-type="doi">10.3390/jcm10112249</pub-id><pub-id pub-id-type="pmid">34067335</pub-id>
</element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Panio</surname><given-names>A.</given-names></name><name><surname>Cava</surname><given-names>C.</given-names></name><name><surname>D'Antona</surname><given-names>S.</given-names></name><name><surname>Bertoli</surname><given-names>G.</given-names></name><name><surname>Porro</surname><given-names>D.</given-names></name></person-group><article-title>Diagnostic circulating miRNAs in sporadic amyotrophic lateral sclerosis</article-title><source>Front. Med.</source><volume>9</volume><year>2022</year><object-id pub-id-type="publisher-id">861960</object-id><pub-id pub-id-type="doi">10.3389/fmed.2022.861960</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H.P.</given-names></name><name><surname>Fu</surname><given-names>M.</given-names></name><name><surname>Masula</surname><given-names>M.</given-names></name><name><surname>Xing</surname><given-names>C.S.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Tan</surname><given-names>J.T.</given-names></name><etal/></person-group><article-title>miR-3064-5p and miR-4745-5p affect heparin sensitivity in patients undergoing cardiac surgery by regulating AT-III and factor X mRNA levels</article-title><source>Front. Physiol.</source><volume>13</volume><year>2022</year><object-id pub-id-type="publisher-id">914333</object-id><pub-id pub-id-type="doi">10.3389/fphys.2022.914333</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Lai</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Man</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Ouyang</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort</article-title><source>Breast Cancer</source><volume>31</volume><year>2024</year><fpage>1046</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1007/s12282-024-01619-w</pub-id><pub-id pub-id-type="pmid">39028497</pub-id>
</element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0170">The following are the Supplementary data to this article.<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.docx"><alt-text>Multimedia component 1</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>Multimedia component 2</title></caption><media xlink:href="mmc2.xlsx"><alt-text>Multimedia component 2</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc3"><caption><title>Multimedia component 3</title></caption><media xlink:href="mmc3.xlsx"><alt-text>Multimedia component 3</alt-text></media></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgement</title><p id="p0165">The authors thank Ms. Otoha Shimura for technical assistance.</p></ack><fn-group><fn id="appsec2" fn-type="supplementary-material"><label>Appendix A</label><p id="p0175">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ncrna.2025.01.001" id="intref0020">https://doi.org/10.1016/j.ncrna.2025.01.001</ext-link>.</p></fn></fn-group></back></article>